OTC - ACTIVE INGREDIENT SECTION
:Each immediate-release tablet contains
Dextromethorphan HBr 20 mg Guaifenesin 400 mg
:Each immediate-release tablet contains
Dextromethorphan HBr 20 mg Guaifenesin 400 mg
Expectorant – Cough Suppressant
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away
Helps loosen phlegm (mucus)
Helps thin bronchial secretions to make coughs more productive
Temporarily relieves cough due to minor throat and bronchial irritation associated with the common cold
WARNINGS:Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug.If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
:Directions:Adults and children 12 years of age and older, take 1 tablet every 4 hours with a full glass of water while symptoms persist.Do not exceed 6 doses in 24 hours.
Children under 12 years of age do not use.
Colloidal Silicon Dioxide, Magnesium Stearate, Maltodextrin, Microcrystalline Cellulose, Povidone, Silicon Dioxide, Sodium Starch Glycolate, Stearic Acid
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-4458-1 | 2021-08-17 | C162847 | 48780-1 | 9855e2a2-42d8-60a7-e053-dbdaa90a05bd | IBU ® Tablets |
| 63629-4458-2 | 2021-08-17 | C162847 | 48780-1 | 9855e2a2-42d8-60a7-e053-dbdaa90a05bd | IBU ® Tablets |
| 63629-4458-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-42d8-60a7-e053-dbdaa90a05bd | IBU ® Tablets |
| 63629-4458-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-42d8-60a7-e053-dbdaa90a05bd | IBU ® Tablets |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-280-06 | EA - Each | 49483-280 | b93edcce-7cd8-4ba1-886f-a2dfc6db3b3c | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | ACTIVE INGREDIENT | 9D2RTI9KYH | 1000 | |
| GUAIFENESIN | ACTIVE INGREDIENT | 495W7451VQ | 1000 | |
| DEXTROMETHORPHAN | ACTIVE MOIETY | 7355X3ROTS | 1000 | |
| GUAIFENESIN | ACTIVE MOIETY | 495W7451VQ | 1000 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1000 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1000 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 1000 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 1000 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1000 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 1000 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1000 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63629-4458 | 63629-4458-1, 63629-4458-2 |
| 49483-280 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GUAIFENESIN | 495W7451VQ | ACTIB |
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POVIDONES | FZ989GH94E | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MUCOSA DM | GUAIFENESIN DEXTROMETHORPHAN | TIME CAP LABORATORIES, INC. | 62c1f4aa-6571-414c-9a58-31e107b7db97 | 2025-02-08 | Warnings | 49483-280 |
| b25bfa71-cfa4-480f-a3a8-b3b3000426f1 | 71b67078-e702-4203-9323-70d03f7cc031 | 2021-08-17 | Warnings | 71b67078-e702-4203-9323-70d03f7cc031 |
Adverse event summaries are temporarily unavailable. Other product information remains available.